Asset Planning Corporation’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$242K Buy
858
+100
+13% +$29K 0.11% 45
2025
Q2
$212K Hold
758
0.11% 43
2025
Q1
$236K Buy
+758
New +$224K 0.14% 39
2024
Q4
Sell
-758
Closed -$244K 44
2024
Q3
$244K Hold
758
0.16% 41
2024
Q2
$237K Sell
758
-225
-23% -$66.1K 0.18% 39
2024
Q1
$279K Sell
983
-225
-19% -$65.8K 0.2% 36
2023
Q4
$348K Hold
1,208
0.27% 28
2023
Q3
$325K Hold
1,208
0.25% 30
2023
Q2
$268K Hold
1,208
0.2% 30
2023
Q1
$292K Hold
1,208
0.23% 28
2022
Q4
$317K Buy
+1,208
New +$324K 0.26% 27
2021
Q1
Sell
-470
Closed -$108K 35
2020
Q4
$108K Buy
+470
New +$108K 0.11% 38

Other funds holding AMGN

Asset Planning Corporation's AMGN Position: Q3 2025 in Review

Asset Planning Corporation increased its Amgen (AMGN) stake by 13% in Q3 2025, buying an estimated $29K and bringing the position to 858 shares worth $242K. The position accounts for 0.11% of the portfolio, ranked #45.

Asset Planning Corporation first reported a position in AMGN in Q4 2020 and has held it in 12 quarters since. The position peaked at $348K in Q4 2023. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Asset Planning Corporation held 858 shares of Amgen worth $242K as of Q3 2025.
  • Asset Planning Corporation bought 100 Amgen shares in Q3 2025, an estimated $29K.
  • Amgen made up 0.11% of Asset Planning Corporation's portfolio in Q3 2025, its #45 holding.
  • Asset Planning Corporation first reported a position in Amgen in Q4 2020 and has held it in 12 quarters since.
  • Asset Planning Corporation's Amgen position peaked at $348K in Q4 2023.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Asset Planning Corporation's 13F filing for Q3 2025, filed 6 Nov 2025.